Ferguson Share Repurchase Program - Weekly Report
Ferguson plc (NYSE: FERG, LSE: FERG) (the "Company") announces today that it purchased a total of 140,000 of its ordinary shares in the period from April 03, 2023 up to and including April 06, 2023 in connection with its $2.5 billion share repurchase program.
Aggregated information about the purchases carried out during this period
Trading day | Aggregate daily volume (in number of shares) | Daily weighted average purchase price of the shares | Trading venue |
April 03, 2023 | 25,000 | 107.450000 | XLON |
April 04, 2023 | 40,000 | 103.550000 | XLON |
April 05, 2023 | 45,000 | 101.000000 | XLON |
April 06, 2023 | 30,000 | 99.300000 | XLON |
The Company intends to hold these shares in treasury. Following the purchase of these shares (including those purchased but not yet settled), the number of shares held by the Company in treasury will be 26,963,647.
Following the purchase of these shares, the remaining number of ordinary shares in issue will be 205,207,535. The figure of 205,207,535 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, and the Commission Delegated Regulation (EU) 2016/1052, detailed information about the individual purchases is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/7004V_1-2023-4-6.pdf
For further information please contact:
Brian Lantz, Vice President IR and Communications +1 224 285 2410
Pete Kennedy, Director of Investor Relations +1 757 603 0111
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.